Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

PSNC: 'Incomprehensible' that budget bypasses pharmacy

It makes no sense that the government’s spring budget plans for new NHS models of care overlook community pharmacy, the Pharmaceutical Services Negotiating Committee (PSNC) has said.

In his first spring budget as chancellor, Philip Hammond announced yesterday (March 8) that £100 million will be invested into A&E departments over the next year, to help them manage winter demand and get patients to primary care faster.

This would "for example, allow for better assessment of patients when they arrive at A&E and increase the provision of on-site GP facilities”, the chancellor explained.

PSNC chief executive Sue Sharpe said it is “incomprehensible” that the NHS is “bypassing [the] established, trusted and popular health resource” of pharmacy so it can place more GPs in hospitals.

“With the right enablers, [pharmacies] could take on the 1.1m visits to emergency departments for patients with minor ailments without delay,” she added.

A consultation in a community pharmacy costs “on average £29” instead of “£147” in A&E, and the plans “overlook the need to prevent the public from needing to attend A&E in the first place”, Ms Sharpe added.

The Royal Pharmaceutical Society’s (RPS) director for England Robbie Turner said he would like to see “further inclusion of pharmacists” in the A&E team, as the benefits of having them have "already been demonstrated".

How will the budget affect locums and businesses?

National insurance

Locums who earn annual profits of between £8,060 and £43,000 – those in ‘Class 4’ – will see their national insurance contributions (NICs) increase from 9% to 10% in April 2018, and then up to 11% a year later, the chancellor confirmed.

Tax-free allowance reduced
 
The tax-free dividend allowance – money paid by a company to its shareholders – will be reduced from £5,000 to £2,000 in April 2018. This means contractors will no longer be able to rely on the tax-free allowance to minimise tax losses, according to pharmacy accountants Warr and Co.

The rates after the tax-free allowance are to remain the same.

Business rates

Mr Hammond also unveiled £435m to help businesses facing increases in their business rates.

This means pharmacies that are no longer eligible for the small business rate relief will have increases in their tax bill capped at £50 per month – or £600 a year.

Councils will also receive £300m to help small businesses, on a case-by-case discretionary basis, the chancellor confirmed.

 

Growing role of STPs

The pharmacy bodies welcomed the chancellor’s recognition of the “growing role of sustainability and transformation plans (STPs)” with a £325m funding pledge.

However, “government continues to under-utilise the long-term and sustainable solution that community pharmacy offers”, Pharmacy Voice pointed out.

"It is clear that community pharmacy needs to continue developing its local engagement and leadership, with local pharmaceutical committees leading the way,” it added.

Mr Turner said the RPS would write to all STP leaders to encourage greater engagement with community pharmacy.

This article was updated on March 10, 2017. 

How does the spring budget affect you?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008634

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel